Exhibit 16.1
Schwartz Levitsky Feldman LLP
Chartered Accountants
April 30, 2007
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: | Skystar Bio-Pharmaceutical Company Commission File No. 000-28153 |
This letter will confirm that we reviewed Item 4.01 of the Company's Form 8-K dated April 30, 2007, captioned "Changes in Registrant’s Certifying Accountant” and that we agree with the statements made therein as they relate to Schwartz Levitsky Feldman LLP.
We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.
Yours very truly,
SCHWARTZ LEVITSKY FELDMAN LLP
/s/ Schwartz Levitsky Feldman LLP
Per: Gerry Goldbert, C.A.
Toronto, Canada